On Wednesday, Following U.S. Stocks were among the “Top Losers”: Cliffs Natural Resources, (NYSE:CLF), BioScrip, (NASDAQ:BIOS), EMC Corporation, (NYSE:EMC), Enphase Energy, (NASDAQ:ENPH)
Cliffs Natural Resources, (NYSE:CLF), with shares dwindled -4.58%, closed at $5.21, hitting new 52-week low of $5.02.
BioScrip, (NASDAQ:BIOS), with shares declined -4.44%, settled at $3.45, hitting new 52-week low of $3.42.
EMC Corporation, (NYSE:EMC), with shares dipped -4.56%, and closed at $25.72.
Enphase Energy, (NASDAQ:ENPH), dropped -4.50%, and closed at $12.51.
Latest NEWS regarding these Stocks are depicted underneath:
Cliffs Natural Resources Inc. (NYSE:CLF)
Cliffs Natural Resources Inc. (CLF), declared the results to date of its pending private offers to exchange its newly issued 7.75% Senior Secured Notes due 2020 for certain outstanding senior unsecured notes of Cliffs. As of 5:00 p.m., New York City time, on March 11, 2015, a total of about $635.0 million principal amount of Existing Notes had been tendered in the Exchange Offers.
Cliffs also declared that the Early Tender Date for the Exchange Offers has been extended to midnight, New York City time, on March 25, 2015. Accordingly, all Existing Notes tendered preceding to the extended Early Tender Date will be eligible to receive the “Total Exchange Consideration”, which comprises the “Early Tender Premium” of $50 in principal amount of Senior Secured Notes.
Cliffs Natural Resources Inc. is a leading mining and natural resources corporation in the United States. The Corporation is a major supplier of iron ore pellets to the North American steel industry from its mines and pellet plants located in Michigan and Minnesota. Cliffs also operates an iron ore mining complex in Western Australia.
BioScrip, Inc. (NASDAQ:BIOS)
BioScrip, Inc. (BIOS), declared the sale of $62.5 million in Series A Convertible Preferred Stock to Coliseum Capital Administration, LLC and associated funds. The Preferred Stock is convertible into 12,088,975 shares of BioScrip’s ordinary stock at a conversion price of $5.17 per share, which was the closing price of BioScrip’s ordinary stock on the NASDAQ Global Market on March 6, 2015. Dividends on the Preferred Stock will be payable quarterly at an annual rate of 8.5% if paid in cash or 11.5% if accrued. As part of the transaction, BioScrip issued to Coliseum Capital warrants for an aggregate of 3.6 million shares of BioScrip stock. Warrants for 1.8 million shares are exercisable at $5.295 per share and warrants for 1.8 million shares are exercisable at $6.596 per share.
In addition, BioScrip intends to conduct a registered rights offering to allow all of BioScrip’s existing stockholders of record, on a date to be determined by the Board, the non-transferable right to purchase their pro rata share of $20.0 million of Preferred Stock and warrants on the same terms as the accomplished private placement to Coliseum Capital. Coliseum Capital and its associates will not take part in the rights offering. Additional details regarding the anticipated rights offering will be comprised of in the Corporation’s Form S-3, which it intends to file with the Securities and Exchange Commission.
The proceeds from the private placement will be used primarily to reduce BioScrip’s outstanding indebtedness.
Christopher Shackelton, a Co-Founder and Managing Partner of Coliseum Capital, will join the BioScrip Board of Directors effective right away.
Richard M. Smith, President and Chief Executive Officer of BioScrip, said, “We are happy to declare this planned investment by Coliseum Capital which we expect will enhance BioScrip’s financial flexibility. We are excited to welcome Chris to our Board and believe his extensive experience in the healthcare services industry will bring added value to our Corporation.”
Mr. Shackelton, said, “Coliseum is excited to be partnering with BioScrip. We believe strongly in the benefits of expanding the delivery of home-based healthcare, which start with improved patient care and outcomes, and extend to lower costs for payers. Specifically, we see noteworthy value to the healthcare system from home-based infusion therapy. I am happy to be joining BioScrip’s Board and I look forward to working with the Corporation.”
BioScrip, Inc. provides home infusion and other home care services, and pharmacy benefit administration (PBM) services in the United States. It operates in two segments, Infusion Services and PBM Services. BioScrip operates with a commitment to bring customer-focused pharmacy and related healthcare infusion therapy services into the home or alternate-site setting. By collaborating with the full spectrum of healthcare professionals and the patient, BioScrip provides cost-effective care that is driven by clinical excellence, customer service, and values that promote positive outcomes and an improved quality of life for those it serves. BioScrip provides its infusion and home care services from over 70 locations across 29 states.
EMC Corporation (NYSE:EMC)
WANdisco (WAND.L), a leading provider of continuous-availability software for global enterprises to meet the challenges of Big Data, recently declared that it has accepted the invitation to join the Open Data Platform (ODP) Initiative — a shared industry effort to promote and advance the state of Apache Hadoop® and Big Data technologies for the enterprise. Members of the ODP Initiative comprise industry-leading firms such as IBM (IBM), EMC (EMC), Hortonworks (HDP), VMware, Verizon (VZ), Splunk (SPLK), General Electric (GE), Pivotal, Cap Gemini (CAP.PA), CenturyLink (CTL), Teradata (TDC), SAS, and Infosys (INFY).
ODP’s mission is to accelerate the delivery of Big Data solutions by providing a well-defined core platform (‘ODP Core’) that enables its users to avoid vendor lock-in. The ODP Core is not a Hadoop distribution, it’s the kernel over which the industry can build enterprise-class Apache Hadoop® distributions that simplifies the development of interoperable technologies, enabling Big Data solutions to flourish atop a ordinary core platform. Now, WANdisco’s patented replication technology will be accessible to global enterprises running mission critical big data applications built on the ODP Core.
“The members of ODP are excited to partner with WANdisco as the newest gold member of ODP. We are incredibly impressed with WANdisco’s patented technology, in addition to their staff of senior core Apache Hadoop committers, some of whom were among the original architects and developers of Hadoop,” said the members of the ODP. “We believe that enterprise users of the ODP Core will benefit immeasurably from WANdisco’s participation.”
“I am delighted that WANdisco has been invited to take part in the ODP Initiative with some of the largest players in the industry,” said David Richards, WANdisco Co-Founder and CEO. “This is clear recognition of the value our patented technology brings to mission critical Hadoop big data deployments, in addition to our commitment to software based on open standards that give customers a choice, instead of locking them in to a proprietary platform.”
“By joining the Open Data Platform, WANdisco is affirming its commitment to providing enterprise Hadoop practitioners maximum choice and compatibility when it comes to the technologies and vendor solutions that make up the emerging Big Data stack,” said Jeff Kelly, Principal Analyst at Wikibon. “The corporation’s Hadoop offerings, focused on continuous availability and active-active data replication, are crucial elements to speeding Hadoop enterprise adoption, which is the ODP’s overarching mission.”
EMC Corporation develops, delivers, and supports information infrastructure and virtual infrastructure technologies, solutions, and services. It offers enterprise storage systems and software deployed in storage area networks (SAN), networked attached storage (NAS), unified storage combining NAS and SAN, object storage, and/or direct attached storage environments, in addition to provides a portfolio of backup products that support a range of enterprise application workloads.
Enphase Energy, Inc. (NASDAQ:ENPH)
Enphase Energy, Inc. (ENPH), declared that it has signed a planned partnership contract with EnergyAustralia to provide its world-leading microinverter-based solar photovoltaic (PV) system to Australian customers. Presently Enphase is exclusively featured as the only microinverter and monitoring platform in EnergyAustralia’s Next Generation Solar product suite.
The Enphase Microinverter System is accessible through EnergyAustralia as either an upfront purchase or with an interest-free payment plan. To find out more, call EnergyAustralia’s Home Services team on 133 349 (Monday-Friday, 8am - 8pm or Saturday, 9am-5pm AEST).
Enphase Energy, Inc., together with its auxiliaries, designs, develops, and sells microinverter systems for the solar photovoltaic industry in the United States and internationally, that raises energy production, simplifies design and installation, improves system uptime and reliability, reduces fire safety risk and provides a platform for intelligent energy administration.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
